0001209191-20-056737.txt : 20201103
0001209191-20-056737.hdr.sgml : 20201103
20201103181549
ACCESSION NUMBER: 0001209191-20-056737
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201031
FILED AS OF DATE: 20201103
DATE AS OF CHANGE: 20201103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alton Gregg H
CENTRAL INDEX KEY: 0001334682
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 201284639
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-31
0
0001000694
NOVAVAX INC
NVAX
0001334682
Alton Gregg H
C/O NOVAVAX, INC.
21 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Stock Option (Right to buy)
80.71
2020-10-31
4
A
0
7700
0.00
A
2021-10-31
2030-10-31
Common Stock
7700
7700
D
One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the October 31, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date.
/s/ John A. Herrmann III, Attorney-in-Fact
2020-11-03